A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

NCT00504270 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Placebo
DRUG: RG3421 120mg
DRUG: RG3421 20mg

Sponsor

Hoffmann-La Roche